Sara Pini
About
Sara Pini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Sara Pini has authored 27 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Sara Pini's work include Colorectal Cancer Treatments and Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Surgical Treatments (6 papers). Sara Pini is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Surgical Treatments (6 papers). Sara Pini collaborates with scholars based in Italy, United Kingdom and United States. Sara Pini's co-authors include Carmine Pinto, Francesca Di Fabio, Andrea Martoni, S. Giaquinta, Raffaele Lombardi, Bruno Cola, Claudio Ceccarelli, Dajana Cuicchi, Paolo Castellucci and Giovanni Luca Frassineti and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Sara Pini
25 papers receiving 263 citations
Peers
Sara Pini
Khalid Jazieh United States
Janine Mahoney United States
Akesu Sujie China
Margherita Ambrosini Italy
Daniela Gianquinto Italy
Ignacio Tusquets Spain
Dalyong Kim South Korea
Özlem Nuray Sever Türkiye
Takeshi Kawakami Japan
Silvana Acquafredda Italy
Citations per year, relative to Sara Pini Sara Pini (= 1×)
peers
Khalid Jazieh
Countries citing papers authored by Sara Pini
Since
Specialization
Citations
This map shows the geographic impact of Sara Pini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pini more than expected).
Fields of papers citing papers by Sara Pini
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sara Pini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pini. The network helps show where Sara Pini may publish in the future.
Co-authorship network of co-authors of Sara Pini
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pini. A scholar is included among the top collaborators of Sara Pini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pini. Sara Pini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Salsi, Valentina, Bruno Fosso, Sara Pini, et al.. (2025). Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis. Nucleic Acids Research. 53(13).
2.
Pini, Sara. (2023). Sulla natura del termine per l'esercizio dell'azione disciplinare. 3(2).
3.
Pini, Sara, Enrico Tagliafico, Antonio La Marca, et al.. (2022). De novo variants and recombination at 4q35: Hints for preimplantation genetic testing in facioscapulohumeral muscular dystrophy. Clinical Genetics. 103(2). 242–246.
4.
Pini, Sara, Hilary Bekker, Mike Bennett, & Lucy Ziegler. (2022). A Structured Intervention to Support Early Palliative Care Conversations for Oncology Patients – A Qualitative Feasibility Study. Clinical Oncology. 34(12). e515–e522.
5.
Zingaretti, Chiara, Giorgio Papiani, Sara Pini, et al.. (2022). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.. Journal of Clinical Oncology. 40(17_suppl). LBA3513–LBA3513.
6.
Rapposelli, Ilario Giovanni, Valentina Zampiga, Ilaria Cangini, et al.. (2021). Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer. BMC Cancer. 21(1). 611–611.
7.
Tovoli, Francesco, Vincenzo Dadduzio, Stefania De Lorenzo, et al.. (2020). 999P Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma. Annals of Oncology. 31. S695–S695.
8.
Casadei‐Gardini, Andrea, Marita Mariotti, Alessandro Lucchesi, et al.. (2016). Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report. BMC Cancer. 16(1). 118–118.
9.
Passardi, Alessandro, Emanuela Scarpi, Stefano Tamberi, et al.. (2015). Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. PLoS ONE. 10(8). e0134732–e0134732.
10.
Pinto, Carmine, Sara Pini, Francesca Di Fabio, et al.. (2014). Treatment Strategy for Rectal Cancer with Synchronous Metastasis: 65 Consecutive Italian Cases from the Bologna Multidisciplinary Rectal Cancer Group. Oncology. 86(3). 135–142.
11.
Menesini, Ersilia, Annalaura Nocentini, Benedetta Emanuela Palladino, & Sara Pini. (2014). Il ciclo della violenza: maltrattamento familiare, bullismo e dating aggression psicologico. Florence Research (University of Florence). 29–46.
12.
Pinto, Carmine, Francesca Di Fabio, Evaristo Maiello, et al.. (2011). Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study). Annals of Oncology. 22(11). 2424–2430.
13.
Pini, Sara, Clare Harley, Dominic O’Connor, & Galina Velikova. (2011). Evaluation of expressive writing as an intervention for patients following a mastectomy for breast cancer – a feasibility study. BMJ Supportive & Palliative Care. 1(Suppl 1). A24.2–A24.
14.
Pinto, Carmine, C. Barone, Armando Orlandi, et al.. (2011). Vitamin K1 cream in the management of skin rash during anti-EGFR monoclonal antibody (mAb) treatment in patients with metastatic cancer: First analysis of an observational Italian study.. Journal of Clinical Oncology. 29(4_suppl). 594–594.
15.
Martoni, Andrea, Francesca Di Fabio, Carmine Pinto, et al.. (2010). Prospective study on the FDG–PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Annals of Oncology. 22(3). 650–656.
16.
Pini, Sara, Carmine Pinto, Bruna Angelelli, et al.. (2010). Multimodal Sequential Approach in Colorectal Cancer Liver Metastases: Hepatic Resection after Yttrium-90 Selective Internal Radiation Therapy and Cetuximab Rescue Treatment. Tumori Journal. 96(1). 157–159.
17.
Lombardi, Raffaele, Dajana Cuicchi, Carmine Pinto, et al.. (2009). Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?. Annals of Surgical Oncology. 17(3). 838–845.
18.
Pini, Sara. (2009). Analysing Turnout in European Elections: National Differences, The Peculiarity of the EU's System and the Abstention of Young People. European View. 8(1). 143–151.
19.
Fabio, Francesco Di, Carmine Pinto, Evaristo Maiello, et al.. (2009). 6045 Safety analysis of starpan (star-02) study with panitumumab, 5-fluorouracil, oxaliplatin and concurrent radiotherapy in locally advanced rectal cancer. European Journal of Cancer Supplements. 7(2). 335–335.
20.
Funaioli, C., Carmine Pinto, Francesco Di Fabio, et al.. (2008). Evaluation of electrolytic imbalance in patients with advanced colorectal and gastric cancer treated with anti-EGFR monoclonal antibody-based therapy. Journal of Clinical Oncology. 26(15_suppl). 14631–14631.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Khalid Jazieh Breakdown of academic impact, for papers by Janine Mahoney Breakdown of academic impact, for papers by Akesu Sujie Breakdown of academic impact, for papers by Margherita Ambrosini Breakdown of academic impact, for papers by Daniela Gianquinto Breakdown of academic impact, for papers by Ignacio Tusquets Breakdown of academic impact, for papers by Dalyong Kim Breakdown of academic impact, for papers by Özlem Nuray Sever Breakdown of academic impact, for papers by Takeshi Kawakami Breakdown of academic impact, for papers by Silvana Acquafredda